コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 This difference was greater in ID than in cardiology.
2 ation across the disciplines of oncology and cardiology.
3 that were once limited only to radiology and cardiology.
4 and is a feared disease across the field of cardiology.
5 might be considered useful in interventional cardiology.
6 the best possible candidates to the field of cardiology.
7 hed Science Award of the American College of Cardiology.
8 d to the current clinical parameters used in cardiology.
9 kills necessary to practice effective sports cardiology.
10 is a decision-making tool in interventional cardiology.
11 re accepted for presentation at Computing in Cardiology.
12 PET tracer with applications in oncology and cardiology.
13 th RD, the safety of the European Society of Cardiology 0/1-hour algorithm is high, but specificity o
14 ostic performance of the European Society of Cardiology 0/1-hour algorithm using hs-cTnT and hs-cTnI
16 ysiology=2; heart failure=11; interventional cardiology=8; P=0.020) and multiregional RCTs had higher
17 Heart Association (AHA)/American College of Cardiology (ACC) atherosclerosis cardiovascular disease
18 evaluation of FALD, the American College of Cardiology (ACC) sponsored a stakeholders meeting on Oct
19 Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapies Registry
20 Thoracic Surgeons (STS)/American College of Cardiology (ACC) TVT (Transcatheter Valve Therapies) reg
22 tions of the most recent American College of Cardiology (ACC)/American Heart Association (AHA) and Eu
25 of Cardiology Adult Congenital and Pediatric Cardiology (ACPC) Section had attempted to create qualit
26 ifferences in faculty rank exist in academic cardiology, adjusting for experience and research produc
28 f adult and pediatric hepatology, congenital cardiology (adult congenital and pediatric cardiology),
29 eart Association and the American College of Cardiology (AHA/ACC) changed 3-hydroxy-3-methyl-glutaryl
30 erican Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline includes reco
31 an Heart Association and American College of Cardiology (AHA/ACC) released a new clinical practice gu
33 erican Heart Association/American College of Cardiology, American Dental Association, and American As
34 erican Heart Association/American College of Cardiology, American Dental Association, and American As
35 ar ASCVD risk (using the American College of Cardiology/American Heart Assocation pooled-cohort equat
36 intermediate risk by the American College of Cardiology/American Heart Association (10-year atheroscl
37 r statin therapy per the American College of Cardiology/American Heart Association (46.2% for those w
41 Task Force (USPSTF) and American College of Cardiology/American Heart Association (ACC/AHA) recommen
42 ars, 62% women), 416 met American College of Cardiology/American Heart Association (ACC/AHA), 205 met
43 ed risk of CVD using the American College of Cardiology/American Heart Association 2013 pooled cohort
44 We compared the 2013 American College of Cardiology/American Heart Association and 2004 Adult Tre
45 pdates in 2016 and 2017) American College of Cardiology/American Heart Association and 2016 European
48 m risk equation, and the American College of Cardiology/American Heart Association ASCVD Pooled Cohor
49 n initiation in the 2017 American College of Cardiology/American Heart Association Blood Pressure (BP
50 ment group from the 2017 American College of Cardiology/American Heart Association BP guideline and t
51 women) eligible for 2013 American College of Cardiology/American Heart Association Cholesterol Guidel
52 treated according to the American College of Cardiology/American Heart Association consensus guidelin
53 RCTs supporting the 2012 American College of Cardiology/American Heart Association Guideline for the
54 14 Focused Update of the American College of Cardiology/American Heart Association Guideline for the
55 terol guideline and 2019 American College of Cardiology/American Heart Association guideline on the p
56 entation of current 2019 American College of Cardiology/American Heart Association guideline recommen
58 eligibility per the 2013 American College of Cardiology/American Heart Association guidelines and 201
59 vention according to the American College of Cardiology/American Heart Association guidelines and usi
60 mendations from the 2017 American College of Cardiology/American Heart Association guidelines for man
62 bility based on the 2013 American College of Cardiology/American Heart Association guidelines for tre
65 ly Implementation of the American College of Cardiology/American Heart Association Guidelines) linked
66 ility was determined per American College of Cardiology/American Heart Association guidelines, and su
67 was defined by the 2013 American College of Cardiology/American Heart Association guidelines, and us
68 er with the most current American College of Cardiology/American Heart Association guidelines, the ne
69 arding the prevalence of American College of Cardiology/American Heart Association HF stages among ol
70 aluated adherence to the American College of Cardiology/American Heart Association performance measur
71 lopes 0.06-1.12) and the American College of Cardiology/American Heart Association Pooled Cohort Equa
72 chart, and the modified American College of Cardiology/American Heart Association Pooled Cohort Equa
73 of mtDNA-CN to the 2013 American College of Cardiology/American Heart Association Pooled Cohorts Equ
74 s, in alignment with the American College of Cardiology/American Heart Association practice guideline
76 specificity for the 2013 American College of Cardiology/American Heart Association recommendations on
77 as examined according to American College of Cardiology/American Heart Association risk category.
79 sera from patients with American College of Cardiology/American Heart Association stage D (N=29) and
80 the accuracy of the 2013 American College of Cardiology/American Heart Association statin eligibility
81 threshold defined by the American College of Cardiology/American Heart Association was largest for CA
83 so been suggested by the American College of Cardiology/American Heart Association/Heart Failure Soci
84 l coronary artery disease is foundational in cardiology, an expanded paradigm is required to address
85 ment guidelines from the American College of Cardiology and American Heart Association (ACC/AHA) reco
86 recommended by the 2018 American College of Cardiology and American Heart Association guidelines, wi
87 ed with that of the 2013 American College of Cardiology and American Heart Association pooled cohort
89 rizes recent promising applications of AI in cardiology and cardiac imaging, which potentially add va
90 n tools are emerging but remain behind adult cardiology and cardiac surgery and leading to partial bl
91 f U.S. physicians who are board certified in cardiology and critical care medicine ("dual-boarded car
92 y all physicians who were board certified in cardiology and critical care medicine before July 2015.
93 8%) maintained active board certification in cardiology and critical care medicine, respectively.
97 s of EA and 366 of AA in the MGH CAMP study (Cardiology and Metabolic Patient) were genotyped on a ge
103 tine clinical practice - American College of Cardiology and the American Heart Association (ACC/AHA)
104 t to guidelines from the European Society of Cardiology and the National Heart Foundation of Australi
107 culation, Journal of the American College of Cardiology, and European Heart Journal) from 2011 to 201
111 eart Rhythm Society, the American College of Cardiology, and the American Heart Association, we ident
112 tistical analysis in exercise physiology and cardiology, and the presented methodology is also applic
113 of CVD, to a vigorous practice of preventive cardiology, and to national policy and programs of healt
114 Digital Platform (Corrie)-includes the first cardiology Apple CareKit smartphone application, which i
116 e 2015 guidelines of the European Society of Cardiology as a major criterion for the diagnosis of dev
117 ctive aims to define the need for preventive cardiology as a unique subspecialty, broaches controvers
118 qualified candidates and overall culture of cardiology as the 2 most significant barriers to augment
119 gy (adult and pediatric), and interventional cardiology, as well as a hospitalist and experts in alar
120 associated clinical fields of pneumology and cardiology, as well as other organ-related biomedical se
122 he novel ACEP guidelines are appropriate for cardiology, but there remain fundamental differences bet
123 HA2DS2-VASc score 2.6 +/- 1.7), 40% received cardiology care and 60% received primary care only.
125 ient and emergency department (ED) access to cardiology care is associated with reduced 30-day readmi
128 and coordinating multiple fields, including cardiology, cellular and molecular biology, biochemistry
130 ess these issues, the PhysioNet/Computing in Cardiology Challenge 2019 facilitated the development of
131 were sourced from the PhysioNet/Computing in Cardiology Challenge 2019 on the "Early Prediction of Se
132 patients were recruited from the outpatient cardiology clinic of the Beatrix Children's Hospital.
133 ation tool delivered electronically before a cardiology clinic visit improved clinician intensificati
135 ensifications from immediately preceding the cardiology clinic visit to 30 days after, compared with
137 care planning), provided by primary care and cardiology clinicians, may be a vehicle to address unmet
138 ting databases or outpatient respiratory and cardiology clinics at the Royal Brompton & Harefield NHS
144 of factors have shifted that have forced the cardiology community to reconsider the role of T2DM in C
147 n Heart Association, and European Society of Cardiology), convened a working group to develop a conse
149 Registry fulfilling the European Society of Cardiology criteria for primary-prevention ICD were incl
150 HODS AND We assessed the Mayo Clinic nuclear cardiology database for all stress SPECT tests performed
151 ssociation and included experts from general cardiology, electrophysiology (adult and pediatric), and
152 adult and pediatric experts from neurology, cardiology, emergency medicine, intensive care medicine,
153 etes mellitus that currently encompasses 203 cardiology, endocrinology, and primary care practices an
154 rdiogram findings to the European Society of Cardiology (ESC) high-sensitivity cardiac troponin (hs-c
157 esearch Programme of the European Society of Cardiology (ESC) to analyze actual management of VHD and
158 ation (ACC/AHA), 205 met European Society of Cardiology (ESC), and 55 met Heart Failure Society of Am
159 rt Association (AHA) and European Society of Cardiology (ESC)/European Society of Hypertension (ESH)
160 rt Disease, and the 2018 European Society of Cardiology/European Association for Cardio-Thoracic Surg
161 iovascular Interventions/European Society of Cardiology/European Association for Cardio-Thoracic Surg
162 >1165 ng/L; and (2) 2015 European Society of Cardiology/European Respiratory Society guidelines cutof
163 approach outlined in the European Society of Cardiology/European Respiratory Society guidelines for t
164 ommendations of the 2018 European Society of Cardiology/European Society of Hypertension guidelines.
170 RA) is an established tool in interventional cardiology for treatment of calcified coronary lesions.
171 was determined using the American College of Cardiology Foundation/American Heart Association criteri
172 nd is recommended by the American College of Cardiology Foundation/American Heart Association guideli
173 (CAD) selected based on American College of Cardiology Foundation/American Heart Association pretest
174 he has received both the European Society of Cardiology Gold Medal and the British Cardiovascular Soc
175 rithm recommended in the European Society of Cardiology guideline combining LOD and 1-hour algorithm.
176 erican Heart Association/American College of Cardiology guideline documents available as of May 2018
180 an Heart Association and American College of Cardiology guidelines on peripheral vascular interventio
181 art Association and 2016 European Society of Cardiology guidelines provide practical evidence-based c
182 erican Heart Association/American College of Cardiology guidelines recommend IA screening, but approp
183 HD patients and the 2015 European Society of Cardiology Guidelines specified recommendations for ICD
188 n the care of CAHAP, the American College of Cardiology has recently established a Sports and Exercis
189 ility of key variables, CPET applications in cardiology have grown impressively to include all forms
190 onths, many important new clinical trials in cardiology have had their first conference presentation
192 ociety, convened, at the American College of Cardiology Heart House, a 2-day multidisciplinary worksh
193 l cardiology (adult congenital and pediatric cardiology), heart failure/transplant, epidemiology, and
194 erican Heart Association/American College of Cardiology/Heart Rhythm Society atrial fibrillation (AF)
195 erican Heart Association/American College of Cardiology/Heart Rhythm Society atrial fibrillation guid
196 erican Heart Association/American College of Cardiology/Heart Rhythm Society Guideline for Management
197 usan F Smith Center for Outcomes Research in Cardiology, Hellman Family Foundation, Department of Vet
198 al Flow Reserve-Stent Evaluated at Rotterdam Cardiology Hospital) is a prospective registry in which
199 FFR SEARCH (Stent Evaluated at Rotterdam Cardiology Hospital) is a prospective single-center regi
201 n Women Committee of the American College of Cardiology, in conjunction with interested parties (from
202 s been the dominant PET tracer in neurology, cardiology, inflammatory diseases, and, most particularl
203 an international group of experts in sports cardiology, inherited cardiac disease, and sports medici
204 which combines expertise from interventional cardiology, interventional radiology, cardiac surgery, c
206 inherent need for patient-specific models in cardiology is clear and is driving the rapid development
210 publication trends of qualitative studies in cardiology journals from 1998 to 2018, novel emerging da
211 erican Heart Association/American College of Cardiology lifestyle guidelines and the 2015 to 2020 Die
212 ermatology, pathology, gastroenterology, and cardiology machine learning articles published in 2015-2
213 disciplinary team approach with members from cardiology, maternal fetal medicine, anesthesia, and nur
214 To investigate the impact that a career in cardiology may have on the family planning decisions of
215 l number of early-career American College of Cardiology members have benefited as funding of the enti
217 erican Heart Association/American College of Cardiology Multi-Society cholesterol guideline and 2019
218 sectional study used the American College of Cardiology National Cardiovascular Data Registry (NCDR)
219 with AF enrolled in the American College of Cardiology National Cardiovascular Data Registry's outpa
220 icine, critical care, cardiac critical care, cardiology, neurology, and nursing specialists who analy
223 rgency department and admitted to either the cardiology or general medicine service with a principal
224 athies result in some of the worst pediatric cardiology outcomes; nearly 40% of children who present
227 way was greater than the European Society of Cardiology pathway overall (P<0.001) and in all subgroup
228 ile at presentation, the European Society of Cardiology pathway ruled out myocardial infarction in 28
230 The treatment of individual patients in cardiology practice increasingly relies on advanced imag
239 es have led to its broad use in the field of cardiology ranging from congenital to vascular and valvu
240 erican Heart Association/American College of Cardiology recommendation to screen patients with coarct
241 Since the original 2010 European Society of Cardiology recommendations for ECG interpretation in ath
246 results and decades of investigation by the cardiology research community, the only treatment with p
247 in achieving data sharing's full potential, cardiology research has the potential to lead the way.
248 -directed echocardiograms, 110 with complete cardiology-reviewed transthoracic echocardiography withi
252 stries, both part of the American College of Cardiology's National Cardiovascular Data Registry.
253 isions of female cardiologists, the Women in Cardiology section of the American College of Cardiology
254 n Heart Association, and American College of Cardiology seeks to provide guidance for clinicians and
255 patients had lower rates of admission to the cardiology service than white patients (adjusted rate ra
260 hrough strengthening collaboration among the cardiology, sleep medicine, and clinical trial communiti
263 r the last decade, outcomes investigators in cardiology still have relatively little guidance on when
265 the time to establish a dedicated preventive cardiology subspecialty to train the clinicians of the f
266 n physician age, sex, years since residency, cardiology subspecialty, publications, National Institut
269 is Professor of Medicine in the Division of Cardiology, the Truth Initiative Distinguished Professor
272 ientific Sessions of the American College of Cardiology titled, "The Academic Medical Center of the F
273 age processing and interpretation in nuclear cardiology to improve disease diagnosis and risk stratif
274 quired to recover scribe costs (range, 0.89 [cardiology] to 1.80 [orthopedic surgery] new patient vis
275 y (472 per year) were required (range, 1.65 [cardiology] to 2.78 [orthopedic surgery] returning visit
276 versity of North Carolina (Chapel Hill), and cardiology training at the University of California, San
278 ety of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry from N
279 Thoracic Surgeons (STS)/American College of Cardiology Transcatheter Valve Therapy (TVT) Registry ca
280 ety of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (TVT) Registry fr
281 ety of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (Novembe
282 iety of Thoracic Surgery/American College of Cardiology Transcatheter Valve Therapy Registry on patie
283 ety of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry was used
284 ety of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy registry were ana
285 ety of Thoracic Surgeons-American College of Cardiology Transcatheter Valve Therapy Registry) from 20
286 ety of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry, we eval
293 ety of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) registry wi
295 atric endocrinology, and adult and pediatric cardiology used the patient-centered Strength of Recomme
297 re model proposed by the European Society of Cardiology was inferior for identifying high-risk patien
299 en are a consistent minority in the field of cardiology, with concerns regarding balancing career and
300 mic Working Group of the American College of Cardiology, with senior leadership support, assessed the